INS and diabetic ketoacidosis: Baseline data, blood glucose (BG) and beta-hydroxybutyrate (BHB) concentration at admission and at “time zero” in dogs with diabetic ketoacidosis treated with IM insulin lispro (Group L) and treated with IV continuous rate infusion of regular insulin (Group R).